<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397495870</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164520.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199507  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1016/S1010-7940(05)80172-1</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1016/S1010-7940(05)80172-1</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Reactive thrombocytosis after coronary bypass surgery. An important risk factor</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Reactive thrombocytosis (RT) has earlier been reported to occur as aresponse to various situations and conditions, such as post- splenectomy,hematopoietic disorders, major trauma and operations, neoplasms andinflammations. In cardiac surgery the main interest has focused onthrombocytopenia that occurs after cardiopulmonary bypass (CPB) and therisk of postoperative bleeding, rather than the possibility of a lateoccurrence of RT as a risk factor for thrombotic complications aftercoronary artery bypass grafting (CABG). Between 1989 and 1992, on routineblood examinations we noticed a group of CABG patients (n = 297, Group II,19.5%) that, 1 week after operation, showed thrombocytosis withsignificantly increased platelet count (521 +/- 96 x 10(3)/mm3) compared topatients with normal platelet counts (Group I, n = 1521, 185 +/- 125 x10(3)/mm3); P &lt; 0.001. Patient characteristics, coronary angiographyfindings, operative data and perioperative complications were analyzed forthe two groups. There were significantly more patients with hyperlipidemia,smoking and previous myocardial infarction in Group II than in Group I; P&lt; 0.05. Age, sex, clinical characteristics, angiography findings andoperative data did not differ between the groups. There were no differencesin postoperative bleeding or the need of transfusion between the groups.However, Group II (RT) patients had significantly more postoperativemyocardial infarctions, 4.4% compared to 0.7% Group I; P &lt; 0.001. Earlysymptomatic vein graft occlusion (0-7 days postoperatively) was notdifferent between the groups, while there were significantly move latesymptomatic vein graft occlusions (7-60 days postoperatively) in Group II(RT) 4.4% than in Group I 1.1%; P &lt; 0.001.(ABSTRACT TRUNCATED AT 250WORDS)</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V.</subfield>
   <subfield code="g">9/7(1995-07), 393-397</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:7&lt;393</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80172-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">abstract</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80172-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V</subfield>
   <subfield code="g">9/7(1995-07), 393-397</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:7&lt;393</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
